In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-α is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)

Cancer Research

Volumn 59, Issue 1, 1999, Pages 205-212

  Wu, Peter C ^a   Alexander, H Richard ^a   Huang, James ^a   Hwu, Patrick ^a   Gnant, Michael ^a   Berger, Adam C ^a   Turner, Ewa ^a   Wilson, Olga ^b   Libutti, Steven K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; HUMAN CELL; MELANOMA; NECROSIS; PRIORITY JOURNAL; THROMBOGENESIS; TUMOR VASCULARIZATION;

ANIMALS; CYTOKINES; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RETROVIRIDAE; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032894132     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. O'Malley, W. E., Achinstein, B., and Shear, M. J. Action of bacterial polysaccharide on tumors. H. Damage of sarcoma 37 by serum of mice treated with Serratia Marcescens polysaccharide, and induced tolerance. J. Natl. Cancer Inst., 29: 1169-1175, 1962.
2. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA, 72: 3666-3670, 1975.
3. Fraker, D. L., Alexander, H. R., and Pass, H. I. Biologic therapy with TNF: systemic administration and isolation-perfusion. In: V. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Biologic Therapy of Cancer, pp. 329-345. Philadelphia: J. B. Lippincott, 1995.
4. Lienard, D., Ewalenko, P., Delmotti, J. J., Renard, N., and Lejeune, F. J. High-dose recombinant tumor necrosis factor a in combination with interferon γ and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin Oncol., 10: 52-60, 1992.
5. Alexander, H. R., Fraker, D. L., and Bartlett, D. L. Isolated limb perfusion for malignant melanoma. Semin. Surg. Oncol., 12: 416-428, 1996.
6. Alexander, H. R., Jr., Bartlett, D. L., Libutti, S. K., Fraker, D. L., Moser, T., and Rosenberg, S. A. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J. Clin. Oncol., 16: 1479-1489, 1998.
7. Bartlett, D. L., Ma. G., Alexander, H. R., Libutti, S. K., and Fraker, D. L. Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics. Cancer (Phila.), 80: 2084-2090, 1997.
8. Eggermont, A. M., Schraffordt, K. H., Klausner, J. M., Lienard, D., Kroon, B. B., Schlag, P. M., Ben-Ari, G., and Lejeune, F. J. Isolation limb perfusion with tumor necrosis factor α and chemotherapy for advanced extremity soft tissue sarcomas. Semin. Oncol., 24: 547-555, 1997.
9. Eggermont, A. M. M., Koops, H. S., Klausner, J. M., Kroon, B. B. R., Schlag, P. M., Liénard, D.v. G. A. N., Hoekstra, H. J., Meller, I., Nieweg, O. E., Kettelhack, C., Ben-Ari, G., Pector, J-C., and Lejeune, F. J. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. Ann. Surg., 224: 756-765, 1996.
10. Barth, R. J., Mulé, J. J., Spiess, P. J., and Rosenberg, S. A. Interferon-γ and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor infiltrating lymphocytes. J. Exp. Med., 173: 647-658, 1991.
11. Asher, A. L., Mulé, J. J., and Rosenberg, S. A. Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells. Cancer Immunol. Immunother., 28: 153-156, 1989.
12. Donato, N. J., and Perez, M. Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21WAFI proteolysis in ME-180 cells. J. Biol. Chem., 273: 5067-5072, 1998.
13. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κ B. Science (Washington DC), 274: 787-789, 1996.
14. Wang, C-Y., Mayo, M. W., and Baldwin, A. S., Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κ B. Science (Washington DC), 274: 784-787, 1996.
15. Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84: 299-308, 1996.
16. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. Involvement of MACH, a novel MORTI/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell, 85: 803-815, 1996.
17. Van De Viel, P. A., Bloksma, N., Kuper, C. F., Hofhuis, F. M., and Willers, J. M. Macroscopic and microscopic early effects of tumour necrosis factor on murine meth A sarcoma, and relation to curative activity. J. Pathol., 75: 65-73, 1989.
18. Renard, N., Liénard, D., Lespagnard, L., Eggermont, A., Heimann, R., and Lejeune, F. Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor α (rTNFγ). Int. J. Cancer, 57: 656-663, 1994.
19. Nawroth, P. P., and Stern, D. M. Modulation of endothelial cell hemostatis properties by tumor necrosis factor. J. Exp. Med., 163: 740-745, 1986.
20. Nawroth, P., Handley, D., Matsueda, G., de Waal, R., Gerlach, H., Blohm, D., and Stem, D. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J. Exp. Med., 168: 637-647, 1988.
21. Clauss, M., Murray, J. C. Vianna, M., de Waal, R., Thurston, G., Nawroth, P., Gerlach, H., Bach, R., Familletti, P. C., and Stern, D. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J. Biol. Chem., 265: 7078-7083, 1990.
22. Olieman, A. F. T., van Ginkel, R. J., Hoekstra, H. J., Mooyaart, E. L., Molenaar, W. M., and Koops, H. S. Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor. Ann. Surg. Oncol., 4: 64-69, 1997.
23. Kao, J., Fan, Y-G., Haehnel, I., Clauss, M., and Stern, D. Endothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response. Behring Inst. Mitt., 92: 92-106, 1993.
24. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
25. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
26. Czubayko, F., Liaudet-Coopman, E. D. E., Aigner, A., Tuveson, A. T., Berchem, G. J., and Wellstein, A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nature (Lond.), 3: 1137-1140, 1997.
27. Peverali, F. A., Mandriota, S. J., Ciana, P., Marelli, R., Quax, P., Rifkin, D. B., Valle, G. D., and Mignatti, P. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endotlhelial cells. J. Cell. Physiol., 161: 1-14, 1994.
28. Kao, J., Ryan, J., Brett, G., Chen, J., Shen, H., Fan, Y-G., Godman, G., Familletei, P., Wang, F., Pan, Y-C., Stern, D., and Clauss, M. Endothelial monocyte-activating polypeptide II: a novel tumor-derived polypeplide that activates host-response mechanisms. J. Biol. Chem., 267: 20239-20247, 1992.
29. Kao, J., Houck, K., Fan, Y., Hzehnel, I., Libutti, S., Kayton, M., Grikscheit, T., Chabot, J., Nowygrod, R., Greenberg, S., Kuang, W-J., Leung, D., Hayward, J., Kisiel, W., Heath, M., Brett, J., and Stern, D. Characterization of a novel tumor-derived cytokine: endothelial-monocyte activating polypeptide II. J. Biol. Chem., 269: 25106-25119, 1994.
30. Marvin, M., Libutti, S., Kayton, M., Kao, J., Hayward, J., Grikscheit, T., Fan, Y., Brett, J., Weinberg, A., Nowygrod, R., LoGerfo, P., Feind, C., Hansen, K., Schwartz, M., Stern, D., and Chabot, J. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor. J. Surg. Res., 63: 248-255, 1996.
31. Wang, G., Chopra, R. K., Royal, R. E., Yang, J. C., Rosenberg, S. A., and Hwu, P. A T cell-independent antitumor response in mice with bone marrow cells retrovirally transduced with an antibody/Fc-γ chain chimeric receptor gene recognizing a human ovarian cancer antigen. Nat. Med., 4: 168-172, 1998.
32. Hoatlin, M. E., Kozak, S. L., Spiro, C., and Kabal, D. Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques. J. Mol. Med., 73: 113-120, 1995.
33. Contrino, J., Hair, G., Kruetzer, D. L., and Rickles, F. R In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat. Med., 2: 209-215, 1996.
34. Tas, M., Houghton, J., Jakobsen, A., Tomachova, T., Carmichael, J., and Murray, J. Cloning and expression of human endothelial-monocyle-activating polypeptide 2 (EMAP-2) and identification of its putative precursor. Cytokine, 9: 535-539, 1997.
35. Libutti, S., Vargas, H., Wu, P., Turner, E., Bartlett, D., Eliot, H., Brown, C., Wong, G., Stern, D., Fraker, D., and Alexander, H. R. Endothelial monocyte activating polypeptide II (EMAP II) induces expression of tumor necrosis factor (TNF) receptor P55 (R1) by endothelial cells. Proc. Soc. Surg. Oncol., Abstract 70, 1997.
36. Tijburg, P. N. M., Ryan, J., Stem, D. M., Wollitzky, B., Rimon, S., Rimon, A., Handley, D., Nawroth, P., Sixma, J. J., and de Grool, P. G. Activation of the coagulation mechanism on tumor necrosis factor-stimulated cultured endothelial cells and their extracellular matrix. J. Biol. Chem., 266: 12067-12074, 1991.
37. Clauss, M., Grell, M., Fangman, C., Fiers, W., Scheurich, P., and Risau, W. Synergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors (Abstract). FEBS Lett., 390: 334-338, 1996.